• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Elevance Health Named in Top 10 of America's Most JUST Companies by JUST Capital and CNBC

    2/5/24 11:30:00 AM ET
    $ELV
    Medical Specialities
    Health Care
    Get the next $ELV alert in real time by email

    The JUST 100 is the only ranking that recognizes American corporate leadership on business issues prioritized by the public.

    Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America's Most JUST Companies. Elevance Health (NYSE:ELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving its workers, customers, communities, the environment, and shareholders.

    The JUST 100 are determined by scoring performance across a full range social impact and sustainability criteria and comparing companies head-to-head. The rankings measure how the nation's largest corporations are performing on the business issues that matter most to Americans. Among companies in the healthcare industry, Elevance Health ranked first in two categories: how a company minimizes its environmental impact and its commitment to good governance.

    "We're grateful to be recognized by JUST Capital as one of America's Most JUST Companies 6 years in a row," said Gail K. Boudreaux, President and CEO of Elevance Health. "This recognition demonstrates our commitment to driving a sustainability strategy that advances whole health and health equity. It also affirms our goal to become a lifetime, trusted health partner - fueled by our passion for making a difference for those we serve and our commitment to driving health beyond healthcare."

    Learn more about Elevance Health's commitment to advancing whole health including its sustainability strategy at https://www.elevancehealth.com/who-we-are/corporate-responsibility.

    JUST Capital is an independent nonprofit that demonstrates how just business – defined by the priorities of the public – is better business. JUST Rankings reveal which companies are doing the best job of creating value for their stakeholders, and consistently show that the companies that score best also outperform their peers financially.

    Compared to their Russell 1000 peers, companies in the JUST 100 on average:

    • Pay 11.8 percentage points more of their workers a family sustaining living wage (78.3%).
    • Provide 7.2 more hours of career development training per employee.
    • Offer 2 more weeks of paid parental leave for both primary caregivers and secondary caregivers.
    • Intake 99% less water per revenue dollar.
    • Emitted 42% less metric tons of CO2 per revenue dollar.
    • Used 29.6 percentage points more renewable energy as a proportion of their total energy use.
    • Have a 4% higher profit margin, 2.9% higher return on equity, and 1.2% higher dividend yield.

    "American capitalism has to work for more Americans. For this to happen, the private sector, and especially big corporations, must take the lead in creating value for all their stakeholders," said JUST Capital CEO Martin Whittaker. "That's exactly what the JUST 100 are doing. They show that just business is better business."

    An exploration of the JUST 100 companies can be found at justcapital.com/rankings.

    About Elevance Health, Inc.

    Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health's companies serve approximately 117 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

    About CNBC

    CNBC is the recognized world leader in business news, providing real-time financial market coverage and business content consumed by more than half a billion people per month across all platforms. The network's 15 live hours a day of news programming in North America (weekdays from 5:00 a.m. - 8:00 p.m. ET) is produced at CNBC's global headquarters in Englewood Cliffs, N.J., and includes reports from CNBC News bureaus worldwide. CNBC at night features a mix of reality programming, CNBC's highly successful series produced exclusively for CNBC and a number of distinctive in-house documentaries.

    CNBC also offers content through its vast portfolio of digital products such as: CNBC.com, which provides financial market news and information to CNBC's investor audience; CNBC Make It, a digital destination focused on making you smarter about how you earn, save and spend your money; CNBC PRO, a premium service that provides in-depth access to Wall Street; a suite of CNBC mobile apps for iOS and Android devices; Amazon Alexa, Google Assistant and Apple Siri voice interfaces; and streaming services including Apple TV, Roku, Amazon Fire TV, Android TV and Samsung Smart TVs. To learn more, visit https://www.cnbc.com/digital-products/.

    Members of the media can receive more information about CNBC and its programming on the NBCUniversal Media Village Web site at http://www.nbcumv.com/programming/cnbc. For more information about NBCUniversal, please visit http://www.NBCUniversal.com.

    About JUST Capital

    The mission of JUST Capital, an independent nonprofit, is to demonstrate how just business – defined by the priorities of the public – is better business. Our goal is to help companies create value for all their stakeholders – their workers, customers, communities, the environment, and shareholders – by focusing on the issues that matter most to Americans. To date, we've polled more than 170,000 Americans on the issues they believe companies should prioritize when it comes to just business behavior, and those insights guide our work. We believe that business and markets can and must be a force for the greater good and that by shifting the resources of the $21.6 trillion private sector, we can drive competition to build a better future for all. Our research, rankings, indexes, initiatives, and new offerings like the JUST Jobs Scorecard help track, analyze, incentivize, and scale corporate stakeholder performance. JUST Capital publishes the annual list of America's Most JUST Companies, the JUST 100, in partnership with CNBC. To learn more, visit: www.JUSTCapital.com.

    About Methodology

    Since 2015, JUST Capital has surveyed more than 170,000 Americans on what Issues they believe U.S. companies should prioritize when it comes to just business behavior. Those Issues become the foundation by which we track, analyze, and incentivize corporate behavior change, including the Rankings of America's Most JUST Companies. JUST evaluated 937 companies across 5 stakeholders, 20 Issues, and 236 raw data points to produce the 2024 Rankings, featuring the JUST 100 and Industry Leader lists.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240205323459/en/

    Get the next $ELV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELV

    DatePrice TargetRatingAnalyst
    4/8/2026$345.00In-line
    Evercore ISI
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    10/14/2025Neutral
    Goldman
    7/21/2025Buy → Hold
    Argus
    7/18/2025$310.00Outperform → Market Perform
    Leerink Partners
    4/15/2025$529.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ELV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/6/26 8:03:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    8/21/25 4:20:38 PM ET
    $ELV
    Medical Specialities
    Health Care

    President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    7/18/25 1:42:51 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    SEC Filings

    View All

    SEC Form PX14A6G filed by Elevance Health Inc.

    PX14A6G - Elevance Health, Inc. (0001156039) (Subject)

    4/7/26 2:58:31 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Elevance Health Inc.

    DEFA14A - Elevance Health, Inc. (0001156039) (Filer)

    3/27/26 4:21:47 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Elevance Health Inc.

    DEF 14A - Elevance Health, Inc. (0001156039) (Filer)

    3/27/26 4:21:11 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schulman Amy W

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/23/26 4:10:37 PM ET
    $ELV
    Medical Specialities
    Health Care

    EVP & President, Commercial Kendrick Charles Morgan Jr sold $910,604 worth of shares (3,196 units at $284.92), decreasing direct ownership by 21% to 11,791 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/9/26 4:45:08 PM ET
    $ELV
    Medical Specialities
    Health Care

    Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/6/26 8:03:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth

    Elevance Health, Inc. (NYSE:ELV) today announced a series of leadership appointments across its Health Benefits and Carelon organizations, positioning the company to strengthen execution, enhance operational performance, and drive continued growth across its businesses. These appointments support the continued expansion of Carelon, Elevance Health's services business, which provides a broad and expanding range of services across care, pharmacy, behavioral health, and data-driven insights to more than 90 million consumers across the healthcare system. As Carelon continues to scale, the updated leadership structure is designed to better align capabilities, accelerate decision-making, and

    3/31/26 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health and National Diaper Bank Network Launch National Pilot to Address Diaper Affordability and Improve Family Health

    National partnership will serve up to 9,000 families across 10 communities while reducing financial strain and studying impacts on maternal and child health Elevance Health (NYSE:ELV) and the National Diaper Bank Network (NDBN) today announced a new national pilot program designed to expand access to diapers for families with infants and young children, helping reduce financial strain while generating evidence on how meeting basic material needs can improve maternal and child health outcomes. The 12-month pilot program will provide free diapers to up to 75 families per month at 10 Welcome Rooms operated by Elevance Health affiliated Medicaid health plans in communities across the countr

    3/3/26 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on Elevance Health with a new price target

    Evercore ISI initiated coverage of Elevance Health with a rating of In-line and set a new price target of $345.00

    4/8/26 8:36:16 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Elevance Health from Outperform to Sector Perform and set a new price target of $358.00

    2/3/26 6:49:01 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Elevance Health from Peer Perform to Outperform and set a new price target of $425.00

    1/8/26 8:09:47 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Financials

    Live finance-specific insights

    View All

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

    4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion 4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33 FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29 Projected FY 2026 GAAP diluted EPS1 to be at least $22.30 Projected FY 2026 adjusted diluted EPS2 to be at least $25.50 Returned $4.1 billion of capital to shareholders in 2025 Reaffirming long-term earnings algorithm; recalibrating segment margin targets Elevance Health, Inc. (NYSE:ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As

    1/28/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

    Elevance Health (NYSE:ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 888-566-0046 - No Access Code (Domestic Replay) 203-369-3677 - No Access Code (International Replay) The replay will be available from 11:30 a.m. EST on January 28, 2026, until the end of the day on Februar

    12/22/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Leadership Updates

    Live Leadership Updates

    View All

    Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization

    Elevance Health, Inc. (NYSE:ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Carelon plays a critical role in advancing the Company's strategy to lower the cost of care. Carelon's operating priorities and client commitments remain unchanged. Felicia Norwood, Executive Vice President and Chief Health Benef

    2/26/26 3:02:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

    The board of directors of Elevance Health (NYSE:ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities. "Amy's record of driving innovation, disciplined investment, an

    12/10/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Appoints Nathan Rich Vice President, Investor Relations

    Elevance Health (NYSE:ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health's Government Health Benefits business. "Nate brings nearly two decades of expe

    11/4/24 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/24 10:02:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/23 12:37:59 PM ET
    $ELV
    Medical Specialities
    Health Care